Bleomycin is known to promote TGF-β, fibroblast proliferation, and collagen synthesis, and, therefore, it is widely used for pulmonary fibrosis in preclinical studies of ALI/ARDS [51,52,53,54]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.